Schedule 13G ownership disclosure
Tokai Pharmaceuticals Inc
Security class unavailable · CUSIP: 67011N204
Event date: 2020-12-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.8900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000929638-21-000023
- Form type
- SC 13G
- Filer
- Cormorant Asset Management, LP
- CIK
- CIK 1583977
- Filed
- Jan 04, 2021
- Reporting period
- Dec 22, 2020
- Description
- Schedule 13G beneficial ownership